Biotechnology Gene therapy is saving children’s lives—but screening to discover who needs it is lagging behind States in the US have been slow to test newborns for genetic conditions. by Emily Mullin 2018-05-31T12:19:00-04:00
Biotechnology FDA halts one of the first human CRISPR studies before it begins by Emily Mullin 2018-05-30T19:02:59-04:00
Biotechnology A stem-cell transplant in the womb appears to have saved a baby girl’s life by Emily Mullin 2018-05-29T13:01:35-04:00
Biotechnology Congo aims to stop its Ebola outbreak with an experimental vaccine by Emily Mullin 2018-05-16T14:04:23-04:00
Biotechnology Before he died, this biohacker was planning a CRISPR trial in Mexico Aaron Traywick and his company, Ascendance Biomedical, are connected to a website advertising a gene-therapy trial for lung cancer. by Emily Mullin 2018-05-04T17:10:00-04:00
Biotechnology This year, the US government plans to start collecting genetic data from 1 million people by Emily Mullin 2018-05-01T17:13:42-04:00
Biotechnology Billions of dollars are at stake, so the fight over who owns CRISPR is back in court by Emily Mullin 2018-04-30T15:26:03-04:00
Biotechnology These DNA testing companies are mainly trying to sell you other stuff Beware of tests offering to make “personalized” lifestyle recommendations. by Emily Mullin 2018-04-26T17:16:00-04:00
Biotechnology A worldwide conservation effort aims to sequence the genomes of 1.5 million organisms by Emily Mullin 2018-04-23T15:26:57-04:00
